1. Home
  2. VERU vs GDO Comparison

VERU vs GDO Comparison

Compare VERU & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • GDO
  • Stock Information
  • Founded
  • VERU 1971
  • GDO 2009
  • Country
  • VERU United States
  • GDO United States
  • Employees
  • VERU N/A
  • GDO N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • GDO Finance Companies
  • Sector
  • VERU Health Care
  • GDO Finance
  • Exchange
  • VERU Nasdaq
  • GDO Nasdaq
  • Market Cap
  • VERU 94.5M
  • GDO 86.3M
  • IPO Year
  • VERU 1990
  • GDO N/A
  • Fundamental
  • Price
  • VERU $0.60
  • GDO $11.81
  • Analyst Decision
  • VERU Strong Buy
  • GDO
  • Analyst Count
  • VERU 2
  • GDO 0
  • Target Price
  • VERU $4.00
  • GDO N/A
  • AVG Volume (30 Days)
  • VERU 2.8M
  • GDO 39.4K
  • Earning Date
  • VERU 08-07-2025
  • GDO 01-01-0001
  • Dividend Yield
  • VERU N/A
  • GDO 9.81%
  • EPS Growth
  • VERU N/A
  • GDO N/A
  • EPS
  • VERU N/A
  • GDO N/A
  • Revenue
  • VERU $16,886,419.00
  • GDO N/A
  • Revenue This Year
  • VERU N/A
  • GDO N/A
  • Revenue Next Year
  • VERU N/A
  • GDO N/A
  • P/E Ratio
  • VERU N/A
  • GDO N/A
  • Revenue Growth
  • VERU 134.43
  • GDO N/A
  • 52 Week Low
  • VERU $0.45
  • GDO $11.21
  • 52 Week High
  • VERU $1.42
  • GDO $13.04
  • Technical
  • Relative Strength Index (RSI)
  • VERU 51.69
  • GDO 69.20
  • Support Level
  • VERU $0.57
  • GDO $11.45
  • Resistance Level
  • VERU $0.73
  • GDO $11.94
  • Average True Range (ATR)
  • VERU 0.05
  • GDO 0.09
  • MACD
  • VERU -0.01
  • GDO 0.02
  • Stochastic Oscillator
  • VERU 29.41
  • GDO 73.47

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: